GZMA Back

granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of GZMA

Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein described here is a T cell- and natural killer cell-specific serine protease that may function as a common component necessary for lysis of target cells by cytotoxic T lymphocytes and natural killer cells.

Community Annotation of GZMA Add / Edit GZMA: Annotations

No community annotations yet for GZMA.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

GZMA is highly significantly mutated in
(none)
GZMA is significantly mutated in
(none)
GZMA is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


Mutation list for GZMA